Emend (Fosaprepitant Dimeglumine Vials) 150mg

Emend (Fosaprepitant Dimeglumine) 150mg vials are prescribed to prevent nausea and vomiting caused by chemotherapy. This antiemetic medication is administered intravenously. Fosaprepitant belongs to the neurokinin-1 receptor antagonist class.

Strength

150mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

MERCK SHARP & DOHME AUSTRALIA PTY. LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant dimeglumine is primarily used to prevent chemotherapy-induced nausea and vomiting. It may also be prescribed for postoperative nausea and vomiting prevention in certain cases. Patients undergoing cancer treatment often receive this medication to manage treatment-related side effects.

Side Effects

Emend works by blocking natural substances in the body that trigger nausea and vomiting. After administration, it helps reduce the likelihood of these symptoms occurring during chemotherapy or surgery. Some patients report feeling more comfortable during treatment when using this medication.

Precautions & Warnings

Store Emend vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Keep out of reach of children. Inform your healthcare provider about all medications you are taking before receiving this injection.

Avoid Interactions

Fosaprepitant may interact with certain medications, including blood thinners, antidepressants, and some antibiotics. Alcohol and sedatives can increase drowsiness when combined with this medication. Always disclose your full medication list to your healthcare provider.

Frequently Asked Questions

It is used to prevent nausea and vomiting caused by chemotherapy or surgery.

Emend is given as an intravenous injection by a healthcare professional.

Some medications may interact; consult your doctor before combining treatments.

Possible effects include headache, fatigue, or diarrhea.

Consult your healthcare provider; safety depends on individual circumstances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.